What is Oculogica?
Oculogica operates at the intersection of ophthalmology and neurology, specializing in the development of advanced eye-tracking technology designed to assess brain function. By monitoring ocular movements, the company provides clinicians with objective data to evaluate neurological health, effectively addressing unmet needs in patient diagnostics. The organization maintains a rigorous commitment to regulatory compliance and technical excellence, ensuring that its quality management systems meet the stringent requirements of both healthcare professionals and regulatory bodies.
The company's market position is defined by its focus on high-precision diagnostic tools that offer a non-invasive alternative to traditional neurological testing. Through continuous monitoring and a dedication to product expertise, Oculogica aims to standardize the assessment of brain function, thereby improving clinical outcomes and operational efficiency in medical facilities worldwide.
How much funding has Oculogica raised?
Oculogica has raised a total of $2.4M across 3 funding rounds:
Private Equity
$599K
Private Equity
$1.7M
Debt
$104K
Private Equity (2014): $599K, investors not publicly disclosed
Private Equity (2016): $1.7M, investors not publicly disclosed
Debt (2021): $104K supported by PPP
Key Investors in Oculogica
PPP
Public-Private Partnership
Undisclosed Investors
Undisclosed Investors
What's next for Oculogica?
With the recent infusion of capital, Oculogica is well-positioned to accelerate its research and development initiatives, focusing on the integration of its eye-tracking solutions into standard clinical workflows. The strategic deployment of these funds will likely prioritize the expansion of technical support infrastructure and the enhancement of its quality assurance systems to support broader market adoption.
Looking ahead, the company is expected to leverage its established diagnostic framework to explore new applications for its technology, potentially entering untapped segments of the neuro-assessment market. By maintaining its focus on regulatory excellence and customer-centric innovation, Oculogica is poised to sustain its growth trajectory and solidify its role as a leader in the evolving landscape of digital health diagnostics.
